BLOG: Guideline addresses NAIMI management, prevention for stem cell transplant recipients
Non-Aspergillus invasive molds infections (NAIMIs) are uncommon but devastating causes of infection in the peri-hematopoietic cell transplant (HCT) period.
BLOG: The role of haploidentical bone marrow transplant for severe aplastic anemia
Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.
BLOG: Optimizing donor selection in aplastic anemia — evolving trends in transplantation
Aplastic anemia is a bone marrow failure process that presents with pancytopenia and bone marrow hypoplasia/aplasia.
BLOG: ‘It’s easier than you think’ to teach genomic alterations in AML
I recently was invited to give a presentation about genomic alterations in AML at the 2024 ASTCT Clinical Education Conference for advanced practice providers, nurses and fellows.
BLOG: Gene therapies for children with sickle cell disease
An increasing number of gene therapies correct genetic disorders, including hemoglobinopathies.
BLOG: Course offers ‘exceptional’ opportunity to engage in scientific, career discussions
I was truly honored to be selected as a scholar for the inaugural ASTCT Laboratory Science Training Course in July.
BLOG: Transformative experience at ASTCT Laboratory Science Training Course
I’m Luca Paruzzo, MD, a hematologist/oncologist working as a postdoctoral fellow at University of Pennsylvania under the mentorship of Marco Ruella, MD.
BLOG: suPAR as a biomarker among patients undergoing allogeneic HCT
Acute kidney injury is a frequent complication following hematopoietic cell transplantation.
BLOG: Predicting sinusoidal obstructive syndrome after allogeneic stem cell transplantation
Sinusoidal obstructive syndrome is a rare but potentially serious complication that can occur after hematopoietic stem cell transplantation.
HSCT for older patients with MDS: Seizing the window of opportunity for high-risk patients
Myelodysplastic syndrome predominantly affects older adults, with median age of onset of 70 years.